Pharmaceutical Lobbying and the Stalled Path of Affordable Prescription Legislation
An individual research project examining the U.S. pharmaceutical lobbying industry and the correlation between lobbying expenditure and the limited passage of affordable prescription drug legislation in Congress, despite consistent voter and constituent prioritization of drug-pricing reform. Mentored by Professor Matt Beverlin.
